234 related articles for article (PubMed ID: 17921707)
1. Dose escalating study of biweekly gemcitabine and carboplatin in patients with advanced cancer.
Dudek AZ; Larson T; Keshtgarpour M; Kumar P
Am J Clin Oncol; 2007 Oct; 30(5):481-6. PubMed ID: 17921707
[TBL] [Abstract][Full Text] [Related]
2. Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Mani S; Vogelzang NJ; Bertucci D; Stadler WM; Schilsky RL; Ratain MJ
Cancer; 2001 Sep; 92(6):1567-76. PubMed ID: 11745236
[TBL] [Abstract][Full Text] [Related]
3. The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.
Davies AM; Ruel C; Lara PN; Lau DH; Gumerlock PH; Bold R; Shibata S; Lenz HJ; Schenkein DP; Gandara DR
J Thorac Oncol; 2008 Jan; 3(1):68-74. PubMed ID: 18166843
[TBL] [Abstract][Full Text] [Related]
4. A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer.
Tomizawa Y; Ishihara S; Iijima H; Imai H; Sato K; Yatomi M; Iwasaki Y; Yamada H; Kobayashi G; Ishida E; Inoue T; Aoki H; Watanabe S; Kawashima O; Mori M; Saito R
Am J Clin Oncol; 2007 Oct; 30(5):498-502. PubMed ID: 17921710
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study.
Ng EW; Sandler AB; Robinson L; Einhorn LH
Am J Clin Oncol; 1999 Dec; 22(6):550-3. PubMed ID: 10597737
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial.
Tassinari D; Drudi G; Panzini I; Pasini G; Arcangeli V; Fochessati F; Gianni L; Mianulli AM; Oliverio G; Pasquini E; Sartori S; Ravaioli A
Int J Clin Oncol; 2001 Dec; 6(6):279-83. PubMed ID: 11828946
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.
Gajra A; Mehdi SA; Kirshner J; Newman N; Graziano SL
Lung Cancer; 2001 May; 32(2):189-96. PubMed ID: 11325490
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
9. Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.
Robert F; Blumenschein G; Herbst RS; Fossella FV; Tseng J; Saleh MN; Needle M
J Clin Oncol; 2005 Dec; 23(36):9089-96. PubMed ID: 16301597
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer.
Sakurai R; Tomizawa Y; Yoshii A; Miura Y; Tsurumaki H; Kaira K; Sunaga N; Kawashima O; Hisada T; Yamada M; Saito R
Cancer Chemother Pharmacol; 2018 Jan; 81(1):103-109. PubMed ID: 29124327
[TBL] [Abstract][Full Text] [Related]
11. A randomized phase II trial of gemcitabine plus carboplatin: biweekly versus standard schedules in patients with advanced non-small cell lung cancer.
Hasegawa Y; Miura D; Kitamura C; Suzuki T; Kobayashi K; Sato N
Chemotherapy; 2013; 59(5):346-53. PubMed ID: 24821009
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.
Soo RA; Lim HL; Wang LZ; Lee HS; Millward MJ; Tok LT; Lee SC; Lehnert M; Goh BC
Cancer Chemother Pharmacol; 2003 Aug; 52(2):153-8. PubMed ID: 12750842
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase I study.
Athanasiadis A; Roussos G; Papakostoulis T; Athanasiadou DC; Stathopoulos GP
Cancer Chemother Pharmacol; 2005 Dec; 56(6):653-8. PubMed ID: 15937714
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer.
Nasr FL; Chahine GY; Kattan JG; Farhat FS; Mokaddem WT; Tueni EA; Dagher JE; Ghosn MG
Clin Breast Cancer; 2004 Jun; 5(2):117-22; discussion 123-4. PubMed ID: 15245614
[TBL] [Abstract][Full Text] [Related]
15. Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy.
Flaherty KT; Stevenson JP; Hahn SM; Redlinger M; O'Dwyer PJ
Cancer Chemother Pharmacol; 2003 Sep; 52(3):217-22. PubMed ID: 12811513
[TBL] [Abstract][Full Text] [Related]
16. Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group.
Karampeazis A; Vamvakas L; Kentepozidis N; Polyzos A; Chandrinos V; Rigas G; Christofyllakis C; Kotsakis A; Hatzidaki D; Pallis AG; Georgoulias V
Clin Lung Cancer; 2016 Nov; 17(6):543-549. PubMed ID: 27397849
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
[TBL] [Abstract][Full Text] [Related]
18. Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.
Iaffaioli RV; Tortoriello A; Facchini G; Caponigro F; Gentile M; Marzano N; Gravina A; Dimitri P; Costagliola G; Ferraro A; Ferrante G; De Marino V; Illiano A
J Clin Oncol; 1999 Mar; 17(3):921-6. PubMed ID: 10071285
[TBL] [Abstract][Full Text] [Related]
19. Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors.
Galsky MD; Posner M; Holcombe RF; Lee KM; Misiukiewicz K; Tsao CK; Godbold J; Soto R; Gimpel-Tetra K; Lowe N; Oh WK
Cancer Chemother Pharmacol; 2014 Sep; 74(3):465-71. PubMed ID: 25023489
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
Masters GA; Argiris AE; Hahn EA; Beck JT; Rausch PG; Ye Z; Monberg MJ; Bloss LP; Curiel RE; Obasaju CK
J Thorac Oncol; 2006 Jan; 1(1):19-24. PubMed ID: 17409822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]